In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 196799-45-8, name is 2,3-Dihydrobenzofuran-7-carbaldehyde, introducing its new discovery. Quality Control of 2,3-Dihydrobenzofuran-7-carbaldehyde
The invention relates to compounds of formula (I) for treating for example sexual dysfunction, wherein R1 is optionally substituted C1-6alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, hydrogen, C1-6alkoxy,–NR2 R3 or–NR4SO2R5; X is the linkage–(CH2)n–or–(CH2)q–O–(wherein Y is attached to the oxygen); wherein one or more hydrogen atoms in linkage X may be replaced independently by C1-4alkoxy; hydroxy; hydroxy(C1-3alkyl); C3-7cycloalkyl; carbocyclyl; heterocyclyl; or by C1-4alkyl optionally substituted by one or more fluoro or phenyl groups; n is 3, 4, 5, 6 or 7; and q is 2, 3, 4, 5 or 6; and Y is phenyl or pyridyl, each of which may be substituted; or two R8 groups on adjacent carbon atoms together with the interconnecting carbon atoms may form a fused optionally substituted 5-or 6-membered carbocyclic or heterocyclyic ring.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 196799-45-8, and how the biochemistry of the body works.Quality Control of 2,3-Dihydrobenzofuran-7-carbaldehyde
Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H1300O – PubChem